John C Lin

US Patent:

7544659, Jun 9, 2009

Filed:

Aug 13, 2004

Appl. No.:

10/917905

Inventors:

John (Chia-Yang) Lin - Mountain View CA, US
Arnon Rosenthal - Woodside CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

A61K 38/17

US Classification:

514 12

Abstract:

The present invention concerns a method of promoting axonal regeneration. In particular, the invention concerns a method of promoting the growth or regeneration of neurons, and treating disease or conditions associated with the loss, loss of function or dysfunction of nerve cells, in particular thalamic nerve cells, by administering a polypeptide having a high degree of sequence identity with a native sequence Netrin G1 (NGL-1) or an agonist thereof.

US Patent:

7935342, May 3, 2011

Filed:

Jan 29, 2007

Appl. No.:

12/278182

Inventors:

John Chia-Yang Lin - Palo Alto CA, US
Arnon Rosenthal - Woodside CA, US

Assignee:

Rinat Neuroscience Corp. - South San Francisco CA

International Classification:

A61K 39/395
A61K 39/44
A61K 39/00
A61K 38/17

US Classification:

4241391, 4241341, 514 212, 514910

Abstract:

This invention relates to methods for treating obesity by peripheral administration of a trkB antagonist. The invention also relates to compositions and kits comprising a trkB antagonist.

US Patent:

8488624, Jul 16, 2013

Filed:

Sep 22, 2010

Appl. No.:

12/924168

Inventors:

John Wei-Iy Lin - Moraga CA, US

Assignee:

Wireless Glue Networks, Inc. - Walnut Creek CA

International Classification:

H04J 3/22

US Classification:

370466, 370401, 370463, 370469

Abstract:

A method and apparatus for implementing a protocol-neutral middleware interface in a home area network. The method comprises receiving one or more data packets from a client device using a first communication protocol, and decoding the data packets into a set of platform independent data objects. The data packets are decoded into the platform independent data objects by utilizing a metadata mapping located within one or more field classes. The apparatus comprises a frame engine, and one or more field classes. The frame engine receives a data packet in a first communication protocol. The frame engine decodes the data packet into a set of platform independent data objects. The frame engine uses a metadata map contained within the one or more field classes to decode the data packet into the set of platform independent data objects.

US Patent:

20050209148, Sep 22, 2005

Filed:

Feb 22, 2005

Appl. No.:

11/064309

Inventors:

Arnon Rosenthal - Woodside CA, US
John Lin - Mountain View CA, US
Jennifer Stratton - Belmont CA, US
Robert Klein - Palo Alto CA, US
Jaume Pons - San Carlos CA, US

International Classification:

A61K038/17

US Classification:

514012000

Abstract:

The invention concerns methods for treating obesity, non-insulin dependent diabetes mellitus, metabolic syndrome, and other related diseases by administering an NT-4/5 polypeptide. The invention also concerns compositions and kits comprising an NT-4/5 polypeptide.

US Patent:

20070031418, Feb 8, 2007

Filed:

Apr 26, 2006

Appl. No.:

11/412685

Inventors:

Lucia Tabares - Sevilla, ES
Arnon Rosenthal - Woodside CA, US
John Lin - Mountain View CA, US

International Classification:

A61K 39/395

US Classification:

424146100

Abstract:

This invention provides methods for the treatment, prevention, and/or amelioration of symptoms relating to lower motor neuron diseases (such as spinal muscular atrophy). The methods comprise administration of an agonist anti-trkC antibody. Compositions and kits are also provided.

US Patent:

20090156489, Jun 18, 2009

Filed:

Sep 12, 2008

Appl. No.:

12/210164

Inventors:

John (Chia-Yang) Lin - Mountain View CA, US
Arnon Rosenthal - Woodside CA, US

International Classification:

A61K 38/16
C12N 5/06

US Classification:

514 12, 435375

Abstract:

The present invention concerns a method of promoting axonal regeneration. In particular, the invention concerns a method of promoting the growth or regeneration of neurons, and treating disease or conditions associated with the loss, loss of function or dysfunction of nerve cells, in particular thalamic nerve cells, by administering a polypeptide having a high degree of sequence identity with a native sequence Netrin G1 (NGL-1) or an agonist thereof.

US Patent:

20090203610, Aug 13, 2009

Filed:

Mar 13, 2009

Appl. No.:

12/404202

Inventors:

Arnon Rosenthal - Woodside CA, US
John C. Lin - Palo Alto CA, US
Jennifer R. Stratton - Belmont CA, US
Robert D. Klein - Palo Alto CA, US
Jaume Pons - San Bruno CA, US

International Classification:

A61K 38/12

US Classification:

514 12

Abstract:

The invention concerns methods for treating obesity, non-insulin dependent diabetes mellitus, metabolic syndrome, and other related diseases by administering an NT-4/5 polypeptide. The invention also concerns compositions and kits comprising an NT-4/5 polypeptide.

US Patent:

20130275607, Oct 17, 2013

Filed:

Jun 11, 2013

Appl. No.:

13/914958

Inventors:

John Wei-ly Lin - Moraga CA, US

International Classification:

H04L 29/06

US Classification:

709230

Abstract:

A method and apparatus for implementing a protocol-neutral middleware interface in a home area network. The method comprises receiving one or more data packets from a client device using a first communication protocol, and decoding the data packets into a set of platform independent data objects. The data packets are decoded into the platform independent data objects by utilizing a metadata mapping located within one or more field classes. The apparatus comprises a frame engine, and one or more field classes. The frame engine receives a data packet in a first communication protocol. The frame engine decodes the data packet into a set of platform independent data objects. The frame engine uses a metadata map contained within the one or more field classes to decode the data packet into the set of platform independent data objects.